Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

PACIRA BIOSCIENCES, INC.

(PCRX)
  Report
Real-time Estimate Cboe BZX  -  01:59 2022-11-28 pm EST
49.07 USD   -1.26%
11/15Sector Update: Health Care Stocks Edge Higher Premarket Tuesday
MT
11/15Pacira BioSciences Reports Higher Exparel Preliminary Net Product Sales in October; Wedbush Maintains Forecast
MT
11/14Pacira BioSciences Reports Higher Exparel Preliminary Net Product Sales in October
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Days
:
Hours
:
Minutes
:
Seconds
Communiqués de presse de la société PACIRA BIOSCIENCES, INC.
11/14Pacira BioSciences Reports Preliminary Net Product Sales of $54.9 Million for October 2..
GL
11/14Pacira BioSciences Reports Preliminary Net Product Sales of $54.9 Million for October 2..
GL
11/08Pacira BioSciences to Present at Two Healthcare Conferences in November
GL
11/03PACIRA BIOSCIENCES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION A..
AQ
11/03Pacira : Q3 Earnings Snapshot
AQ
11/03Pacira BioSciences Reports Third Quarter 2022 Financial Results
GL
11/03Pacira BioSciences Reports Third Quarter 2022 Financial Results
AQ
10/20Pacira to Report Third Quarter 2022 Financial Results on Thursday November 3, 2022
GL
10/20Pacira to Report Third Quarter 2022 Financial Results on Thursday November 3, 2022
AQ
10/13Pacira BioSciences Reports Preliminary Third Quarter 2022 Revenue of $167.5 Million
GL
10/13Pacira BioSciences Reports Preliminary Third Quarter 2022 Revenue of $167.5 Million
AQ
09/27Sevāredent Sourcing Solutions and Pacira BioSciences Collaborate to Provide Expand..
GL
09/27Sevāredent Sourcing Solutions and Pacira BioSciences Collaborate to Provide Expand..
AQ
09/21Pacira BioSciences Announces Positive Topline Data from Phase 3 Study of EXPAREL as a S..
GL
09/21Pacira BioSciences Announces Positive Topline Data from Phase 3 Study of EXPAREL as a S..
GL
09/20Pacira Receives Positive CHMP Opinion for EXPAREL® for the Treatment of Postsurgical Pa..
GL
09/13Pacira BioSciences Reports Preliminary Net Product Sales of $59.1 Million for August 20..
GL
09/13Pacira BioSciences Reports Preliminary Net Product Sales of $59.1 Million for August 20..
GL
09/07Pacira BioSciences Announces Positive Topline Data from Phase 3 Study of EXPAREL as a S..
GL
08/10Pacira Biosciences : Reports Preliminary Net Product Sales of $50.2 Million for July 2022 ..
PU
08/10Pacira BioSciences Reports Preliminary Net Product Sales of $50.2 Million for July 2022
GL
08/09NFL Alumni Association and Pacira BioSciences Team Up to Educate Athletes and Communiti..
GL
08/09NFL Alumni Association and Pacira BioSciences Team Up to Educate Athletes and Communiti..
GL
08/03PACIRA BIOSCIENCES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION A..
AQ
08/03Pacira Biosciences : Reports Second Quarter 2022 Financial Results - Form 8-K
PU
08/03Pacira : Q2 Earnings Snapshot
AQ
08/03Pacira BioSciences Reports Second Quarter 2022 Financial Results
GL
08/03Pacira BioSciences Reports Second Quarter 2022 Financial Results
AQ
08/02Pacira BioSciences to Participate in Fireside Chat at the 2022 Wedbush PacGrow Healthca..
GL
08/02Pacira BioSciences to Participate in Fireside Chat at the 2022 Wedbush PacGrow Healthca..
AQ
07/27Pacira to Report Second Quarter 2022 Financial Results on Wednesday August 3, 2022
GL
07/27Pacira to Report Second Quarter 2022 Financial Results on Wednesday August 3, 2022
GL
07/14Pacira Biosciences : Reports Preliminary Second Quarter 2022 Revenue of $169.4 Million - F..
PU
07/14Pacira BioSciences Reports Preliminary Second Quarter 2022 Revenue of $169.4 Million
GL
06/16National Safety Council and Pacira BioSciences Partner to Launch an Employee-Based Prog..
GL
06/16National Safety Council and Pacira BioSciences Partner to Launch an Employee-Based Prog..
PR
06/14Pacira Biosciences : Reports Preliminary Net Product Sales for EXPAREL and iovera° of $46...
PU
06/14Pacira BioSciences Reports Preliminary Net Product Sales for EXPAREL and iovera° of $46..
GL
06/14Pacira BioSciences Reports Preliminary Net Product Sales for EXPAREL and iovera° of $46..
AQ
06/10Pacira Biosciences, Inc. : Change in Directors or Principal Officers, Submission of Matter..
AQ
06/02Pacira BioSciences to Participate in Fireside Chat at the Jefferies Healthcare Conferen..
GL
05/25Pacira BioSciences and the National Senior Games Association Break a GUINNESS WORLD REC..
PR
05/12Pacira BioSciences Reports Preliminary Net Product Sales for EXPAREL and iovera° of $45..
GL
05/10Pacira BioSciences to Present at Two Healthcare Conferences in May
GL
05/10Pacira BioSciences to Present at Two Healthcare Conferences in May
AQ
05/04PACIRA BIOSCIENCES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION A..
AQ
05/04Pacira : Q1 Earnings Snapshot
AQ
05/04Pacira Biosciences, Inc. : Results of Operations and Financial Condition, Change in Direct..
AQ
05/04Pacira BioSciences Reports First Quarter 2022 Financial Results
GL
05/04Pacira BioSciences Reports First Quarter 2022 Financial Results
AQ
04/27Pacira to Report First Quarter 2022 Financial Results on Wednesday May 4, 2022
GL
04/12Pacira Biosciences : Reports Preliminary Revenues of $157.4 to $158.4 Million for the Firs..
PU
04/12Pacira BioSciences Reports Preliminary Revenues of $157.4 to $158.4 Million for the Fir..
AQ
04/05Pacira BioSciences to Participate in Fireside Chat at the 21st Annual Needham Virtual H..
AQ
03/15Pacira Biosciences : Reports Preliminary Net Product Sales for EXPAREL and iovera° of $42...
PU
03/15Pacira BioSciences Reports Preliminary Net Product Sales for EXPAREL and iovera° of $4..
AQ
03/09Pacira BioSciences to Participate in Fireside Chat at the Barclays Global Healthcare Co..
AQ
02/28PACIRA BIOSCIENCES, INC. Management's Discussion and Analysis of Financial Condition a..
AQ
02/24Pacira : Q4 Earnings Snapshot
AQ
02/24Pacira Biosciences : Reports Full-Year and Fourth Quarter 2021 Financial Results - Form 8-..
PU
02/24Pacira BioSciences Reports Full-Year and Fourth Quarter 2021 Financial Results
AQ
02/16Pacira to Report 2021 Financial Results on Thursday February 24, 2022
AQ
02/15Pacira Biosciences : Reports Preliminary Net Product Sales for EXPAREL and iovera° of $37...
PU
02/15Pacira BioSciences Reports Preliminary Net Product Sales for EXPAREL and iovera° of $37..
GL
02/07PACIRA BIOSCIENCES, INC. Financial Statements and Exhibits (form 8-K/A)
AQ
02/07Pacira Biosciences : UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL STATEMENTS - Form 8-..
PU
01/06Pacira Biosciences : Reports Preliminary Unaudited Total Revenue for 2021 of of $540.7 Mil..
PU
01/06Pacira Reports Preliminary Unaudited Total Revenue for 2021 of $540.7 Million to $541.7..
AQ
01/03Pacira BioSciences to Present at the 40th Annual J.P. Morgan Healthcare Conference
AQ
2021Pacira Biosciences : Announces Closing of $375 Million Five-Year Term Loan B - Form 8-K
PU
2021Pacira Biosciences, Inc. : Entry into a Material Definitive Agreement, Creation of a Direc..
AQ
2021Pacira BioSciences Announces Closing of $375 Million Five-Year Term Loan B
GL
2021Pacira Biosciences : Reports Preliminary Net Product Sales for EXPAREL® and iovera° of $48..
PU
2021Pacira BioSciences Reports Preliminary Net Product Sales for EXPAREL® and iovera° of $4..
AQ
2021Pacira BioSciences to Present at the Piper Sandler 33rd Annual Virtual Healthcare Confe..
GL
1  2  3  4  5  6  7Next
Upcoming event on PACIRA BIOSCIENCES, INC.